Oct 8, 2025 3:45pm EDT bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules
Oct 7, 2025 8:00am EDT bioAffinity Technologies Reports Record Growth in CyPath® Lung Test Volume for Third Quarter 2025